The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Study of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior Therapy
Official Title: A Phase 2 Trial of Single-Agent Amrubicin in Patients With Extensive Disease Small Cell Lung Cancer That is Refractory or Progressive Within 90 Days of Completion of First Line Platinum-based Chemotherapy
Study ID: NCT00375193
Brief Summary: The purpose of the study is to evaluate the objective tumor response rate of amrubicin when administered as second-line therapy to ED-SCLC patients who have refractory or progressive disease.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Hematology Oncology Associates, Phoenix, Arizona, United States
Rocky Mountain Cancer Center - Sky Ridge, Lone Tree, Colorado, United States
Ocala Oncology Center, Ocala, Florida, United States
Cancer Centers of Florida, PA, Ocoee, Florida, United States
John B. Amos Cancer Center, Columbus, Georgia, United States
Cancer Care & Hematology Specialists of Chicago, Niles, Illinois, United States
Oncology & Hematology of Central Illinois, Peoria, Illinois, United States
Blessing Cancer Center, Quincy, Illinois, United States
Central Indiana Cancer Centers - Indianapolis, Indianapolis, Indiana, United States
Norton Healthcare - Louisville Oncology, Louisville, Kentucky, United States
Maryland Oncology Hematology, PA, Columbia, Maryland, United States
Alliance Hematology Oncology, PA - Carroll County Cancer Center, Westminster, Maryland, United States
West Michigan Cancer Center, Kalamazoo, Michigan, United States
Minnesota Onc/Hem, PA - Minneapolis, Minneapolis, Minnesota, United States
University of MN/Division of Hematology, Oncology & Transplantation, Minneapolis, Minnesota, United States
Missouri Cancer Associates, Columbia, Missouri, United States
St. Joseph Oncology, Inc., Saint Joseph, Missouri, United States
Arch Medical Group - Arch Medical Services, Inc., Saint Louis, Missouri, United States
Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States
New York Oncology Hematology, PC, Albany, New York, United States
SUNY Upstate Medical Center, Syracuse, New York, United States
Northwestern Carolina Oncology & Hematology, Hickory, North Carolina, United States
Raleigh Hematology Oncology Associates, Raleigh, North Carolina, United States
Willamette Valley Cancer Center, Eugene, Oregon, United States
Medical Oncology Associates, Kingston, Pennsylvania, United States
University of Tennessee Medical Center, Knoxville, Knoxville, Tennessee, United States
Sarah Cannon, Nashville, Tennessee, United States
Texas Oncology - Amarillo, Amarillo, Texas, United States
Mamie McFaddin Ward Cancer Center, Beaumont, Texas, United States
Texas Oncology, PA - Bedford, Bedford, Texas, United States
Texas Cancer Center at Medical City, Dallas, Texas, United States
Texas Oncology, P.A. - Dallas, Dallas, Texas, United States
Texas Oncology, P.A., Sammons Cancer Center, Dallas, Texas, United States
Texas Oncology, PA - Fort Worth, Fort Worth, Texas, United States
West Texas Cancer Center, Odessa, Texas, United States
Tyler Cancer Center, Tyler, Texas, United States
Texas Oncology Cancer Care and Research Center, Waco, Texas, United States
Texas Oncology, PA - Deke Slayton Cancer Center, Webster, Texas, United States
Texas Oncology - Wichita Falls, Wichita Falls, Texas, United States
Virginia Oncology Associates - Norfolk, VA, Norfolk, Virginia, United States
Oncology & Hematology Associates of Southwest Virginia, Inc., Salem, Virginia, United States
Puget Sound Cancer Center, Seattle, Washington, United States
Northwest Cancer Specialists - Vancouver Cancer Center, Vancouver, Washington, United States
Yakima Regional Cancer Care Center - North Star Lodge Cancer Center, Yakima, Washington, United States
Free University Medical Center, Amsterdam, , Netherlands
Royal Marsden Hospital in Downs Road, Sutton, Surrey, United Kingdom
Name: Richard S Ungerleider, MD
Affiliation: Theradex
Role: STUDY_DIRECTOR